World Health Organization (2021) Suicide in the world – Global Health Estimates. https://apps.who.int/iris/bitstream/handle/10665/326948/WHO-MSD-MER-19.3-eng.pdf. Accessed 5 January 2024
Song Y, Rhee SJ, Lee H, Kim MJ, Shin D, Ahn YM (2020) Comparison of suicide risk by Mental Illness: a Retrospective Review of 14-Year Electronic Medical records. J Korean Med Sci 35(47):e402. https://doi.org/10.3346/jkms.2020.35.e402
Article PubMed PubMed Central Google Scholar
GBD2016DandIIandPC (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet 390(10100):1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2. Erratum in: Lancet. 2017;390(10106):e38
American Psychiatric Association, DSM-5 Task Force (2013) Diagnostic and statistical manual of mental disorders: DSM-5™, 5th edn. American Psychiatric Publishing, Inc., Arlington, VA
Sokero TP, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-mielonen PS, Isometsä ET (2003) Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry 64(9):1094–1100. https://doi.org/10.4088/jcp.v64n0916
World Health Organization (2017) Depression and Other Common Mental Disorders – Global Health Estimates https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf. Accessed 7 February 2024
Isometsä E (2014) Suicidal behaviour in mood disorders—who, when, and why? Can J Psychiatry 59(3):120–130. https://doi.org/10.1177/070674371405900303
Article PubMed PubMed Central Google Scholar
Novick DM, Swartz HA, Frank E (2010) Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 12(1):1–9. https://doi.org/10.1111/j.1399-5618.2009.00786.x
Article PubMed PubMed Central Google Scholar
Gentile G, Tambuzzi S, Calati R, Zoja R (2022) A descriptive cohort of suicidal Cancer patients: analysis of the autopsy Case Series from 1993 to 2019 in Milan (Italy). Int J Environ Res Public Health 19(2):829. https://doi.org/10.3390/ijerph19020829
Article PubMed PubMed Central Google Scholar
Mann JJ, Apter A, Bertolote J et al (2005) Suicide prevention strategies. JAMA 294(16):2064. https://doi.org/10.1001/jama.294.16.2064
Article PubMed CAS Google Scholar
Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, Carli V, Höschl C, Barzilay R, Balazs J, Purebl G, Kahn JP, Sáiz PA, Lipsicas CB, Bobes J, Cozman D, Hegerl U, Zohar J (2016) Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry 3(7):646–659. https://doi.org/10.1016/S2215-0366(16)30030-X
Mahon K, Burdick KE, Wu J, Ardekani BA, Szeszko PR (2012) Relationship between suicidality and impulsivity in bipolar I disorder: a diffusion tensor imaging study. Bipolar Disord 14(1):80–89. https://doi.org/10.1111/j.1399-5618.2012.00984.x
Article PubMed PubMed Central Google Scholar
Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN (1991) Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 303(6804):685–692. https://doi.org/10.1136/bmj.303.6804.685. Erratum in: BMJ 1991;303(6808):968
Jick H (2004) Antidepressants and the risk of suicidal behaviors. JAMA 292(3):338. https://doi.org/10.1001/jama.292.3.338
Article PubMed CAS Google Scholar
King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, Lombroso P, Scahill L (1991) Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 30(2):179–186. https://doi.org/10.1097/00004583-199103000-00003
Article PubMed CAS Google Scholar
Teicher MH, Glod C, Cole JO (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147(2):207–210. https://doi.org/10.1176/ajp.147.2.207
Article PubMed CAS Google Scholar
Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G (2009) Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to us food and drug administration. BMJ 339:b2880. https://doi.org/10.1136/bmj.b2880
Article PubMed PubMed Central Google Scholar
Brent DA (2016) Antidepressants and suicidality. Psychiatr Clin North Am 39(3):503–512. https://doi.org/10.1016/j.psc.2016.04.002
Cato V, Holländare F, Nordenskjöld A, Sellin T (2019) Association between benzodiazepines and suicide risk: a matched case-control study. BMC Psychiatry 26(1):317. https://doi.org/10.1186/s12888-019-2312-3
Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R (2023) Novel and emerging treatments for major depression. Lancet 401(10371):141–153. https://doi.org/10.1016/S0140-6736(22)02080-3
Article PubMed CAS Google Scholar
Wilkinson ST, Trujillo Diaz D, Rupp ZW, Kidambi A, Ramirez KL, Flores JM, Avila-Quintero VJ, Rhee TG, Olfson M, Bloch MH (2022) Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis. Depress Anxiety 39(2):100–112. https://doi.org/10.1002/da.23222
Article PubMed CAS Google Scholar
World Health Organization (2003) Adherence to long-term therapies: evidence for action https://iris.who.int/bitstream/handle/10665/42682/9241545992.pdf?sequence=1&isAllowed=y. Accessed 25 June 2024
Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK (2008) Medication compliance and persistence: terminology and definitions. Value Health 11(1):44–47. https://doi.org/10.1111/j.1524-4733.2007.00213.x
Kang JS, Lee MH (2009) Overview of therapeutic drug monitoring. Korean J Intern Med 24(1):1–10. https://doi.org/10.3904/kjim.2009.24.1.1
Article PubMed PubMed Central Google Scholar
Al-Taani GM, Yehya A, Albals D, Alsous M (2024) Assessment of adherence to carbamazepine using plasma and saliva samples, a study from Jordan. Heliyon 10(5):e26736. https://doi.org/10.1016/j.heliyon.2024.e26736
Article PubMed PubMed Central CAS Google Scholar
Cohan SL (1981) Antiepileptic therapeutic drug monitoring. Clin Lab Med 1(3):479–500
Article PubMed CAS Google Scholar
Fiaturi N, Greenblatt DJ (2019) Therapeutic drug monitoring of antidepressants. Handb Exp Pharmacol 250:115–133. https://doi.org/10.1007/164_2018_161
Article PubMed CAS Google Scholar
McCutcheon R, Beck K, D’Ambrosio E, Donocik J, Gobjila C, Jauhar S, Kaar S, Pillinger T, Reis Marques T, Rogdaki M, Howes OD (2018) Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia. Acta Psychiatr Scand 137(1):39–46. https://doi.org/10.1111/acps.12825
Article PubMed CAS Google Scholar
Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A (2020) Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Rev 9(1):17. https://doi.org/10.1186/s13643-020-1274-3
Article PubMed PubMed Central Google Scholar
Raouf M, Bettinger JJ, Fudin J (2018) A practical guide to urine drug monitoring. Fed Pract 35(4):38–44
PubMed PubMed Central Google Scholar
Strano Rossi S, Frison G, Chericoni S, Bertol Elisabetta, Favretto D, Pichini S, Salamone A, Tagliaro F, Vignali C (2023) Linee Guida per la determinazione di sostanze stupefacenti e psicotrope su campioni biologici con finalità tossicologico-forensi e medico-legali [Guidelines for the determination of narcotic and psychotropic substances on biological samples for toxicological-forensic and medico-legal purposes]. La Rivista Italiana Della Med Di Laboratorio 19(3):192–205. https://doi.org/10.23736/S1825-859X.23.00204-9
LeBeau MA (2020) ANSI/ASB Standard 036 for Method Validation in Forensic Toxicology Has Replaced SWGTOX’s Version. J Anal Toxicol 44(4):414. https://doi.org/10.1093/jat/bkz115. PMID: 32091110
Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A (2012) Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 16(4):R136. https://doi.org/10.1186/cc11441
Comments (0)